Microbot Medical (MBOT) said Wednesday it has obtained Institutional Review Board approval and signed an agreement with Baptist Hospital of Miami for a pivotal human clinical trial of Microbot's Liberty endovascular robotic surgical system.
The company said Baptist Hospital will be its second clinical trial site. The agreement includes the Miami Cardiac and Vascular Institute and Miami Cancer Institute, Microbot Medical added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments